RIVM prepares a recommended list of banned substances in tobacco products and e-cigarettes The goal of the European Tobacco Products Directive is to make tobacco products and e-cigarettes less harmful, addictive and attractive. The directive does not specifically state which substances are not allowed in tobacco products and e-cigarettes.
Drop in and get vaccinated without an appointment on HPV Awareness Day Saturday 4 March is HPV Awareness Day. It is a day to stop and think about the human papillomavirus (HPV) and the six kinds of cancer it can cause. These cancers affect both men and women.
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
More attention needed for potential impact of drug waste on drinking water quality Drug waste contains substances that are harmful to the quality of drinking water. Because this waste is dumped illegally, these substances can end up in sources of drinking water.
Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.
New test for Lyme disease is not reliable To determine whether someone has Lyme disease, doctors in the Netherlands often use antibody tests. For some time now, so-called cellular tests have been available on the market.
RIVM: seven e-cigarette flavourings with tobacco-taste pose health risk The Dutch government only wants to allow 23 e-cigarette flavourings with a tobacco-taste. RIVM examined whether these 23 flavourings are harmful to people’s health.
Ten years of Tick Radar 80,000 tick bite reports; chances of being bitten highest in Drenthe After recording 80,000 tick bites in 10 years via Tekenradar.nl, we now know that you are most likely to be bitten by a tick in Drenthe. Quickly removing the tick halves the chance of contracting Lyme disease.
RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
New WHO Collaborating Centre hosted by RIVM combines laboratory preparedness and biorisk RIVM has been designated WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk by the World Health Organization (WHO).